Screener
Opus Genetics IRD Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
| Assets | As of / March 31,2026 / (Unaudited) | As of / December 31,2025 |
|---|---|---|
| Prepaids and other current assets | 3,927 | 1,788 |
| Total current assets | 66,601 | 50,044 |
| Property and equipment, net | 186 | 199 |
| Total assets | $66,787 | $50,243 |
| Liabilities, convertible preferred stock and stockholders’ (deficit) equity | ||
| Current liabilities: | ||
| Accounts payable | $4,422 | $3,293 |
| Accrued expenses | 4,918 | 4,488 |
Item 1. Financial Statements
FAQ
- What is Opus Genetics's total assets?
- Opus Genetics (IRD) reported total assets of $66.79M in Q1 2026.
- How has Opus Genetics's total assets changed year-over-year?
- Opus Genetics's total assets increased by 38.7% year-over-year, from $48.17M to $66.79M.
- What is the long-term trend for Opus Genetics's total assets?
- Over 5 years (2020 to 2025), Opus Genetics's total assets has grown at a 23.2% compound annual growth rate (CAGR), from $17.68M to $50.24M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Opus Genetics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude